Tech Company Financing Transactions
AtomVie Global Radiopharma Funding Round
AtomVie Global Radiopharma, based in Hamilton, ON, scored investment capital from Avego Management.
Transaction Overview
Company Name
Announced On
8/25/2022
Transaction Type
Amount
Unknown
Round
Series A
Investors
Avego Management (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its current clinical GMP manufacturing capacity of radiopharmaceutical products to include commercial stage production through the construction of a new facility designed to accommodate multiple isotopes.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
1280 Main St. W., NRB-A316
Hamilton, ON, L8S 4K1
CA
Hamilton, ON, L8S 4K1
CA
Phone
Undisclosed
Website
Email Address
Overview
Leveraging over ten years of expertise in the GMP manufacturing and global distribution of radiopharmaceuticals, the Centre for Probe Development and Commercialization (CPDC) is launching AtomVie Global Radiopharma Inc. (AtomVie), a global leading Contract Development and Manufacturing Organization (CDMO). AtomVie empowers next-generation radiotherapeutics and thrives to support its partners from early clinical development to commercial manufacturing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruno Paquin
Browse more venture capital transactions:
Prev: 8/25/2022: Nreal venture capital transaction
Next: 8/25/2022: 3T Biosciences venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs